AllSquare Wealth Management’s Albany Molecular Research Inc AMRI Stock Holding History

AllSquare Wealth Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,532	Closed	-$77K	–	385
2017 Q2	$77K	Sell	3,532 -1,700	-32%	-$30.9K	0.08%	61
2017 Q1	$73K	Hold	5,232	–	–	0.06%	110
2016 Q4	$98K	Buy	+5,232	New	+$88.9K	0.09%	97

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

AllSquare Wealth Management's AMRI Position: Q3 2017 in Review

AllSquare Wealth Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 3,532 shares — an estimated $77K sold.

AllSquare Wealth Management first reported a position in AMRI in Q4 2016 and held it in 3 quarters. The position peaked at $98K in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

AllSquare Wealth Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
AllSquare Wealth Management sold 3,532 Albany Molecular Research Inc shares in Q3 2017, an estimated $77K.
AllSquare Wealth Management first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 3 quarters.
AllSquare Wealth Management's Albany Molecular Research Inc position peaked at $98K in Q4 2016.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on AllSquare Wealth Management's 13F filing for Q3 2017, filed 6 Nov 2017.